UK MHRA approves Marksans All in One oral solution
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
The clinical research organisation located in Hyderabad is a USFDA inspected facility
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
The facility will have a capacity to manufacture upto 3 million tubes monthly
Subscribe To Our Newsletter & Stay Updated